Latest filing published 17 May 2024 for HEAT BIOLOGICS, INC..
Insider track record
No signal scores available.
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +34.8%Entry US$65,909.38 · Close at T+365 US$88,846.39
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jeffrey Alan Wolf: trading record in brief
This profile gathers the share dealings of Jeffrey Alan Wolf across 2 companies, led by Heat Biologics, Inc. and Theriva Biologics, Inc. In total, 20 filings cover trades dated from 29 July 2013 to 16 May 2024.
The open-market record is one-sided, with 4 purchases worth €7,524 and not one sale. The amount is not disclosed for 1 filing. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 14 share grants and 1 option exercise.
Half of the purchases are above €1,181 and half below. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 0% of cases; the median change was -13.2%. These figures describe past trades and do not predict future prices.
The latest filing, published on 17 May 2024, reports a share grant in Heat Biologics, Inc. The last insider purchase was made public on 20 May 2014, 4,555 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jeffrey Alan Wolf
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,500,000 sharesCommon StockSEC:0001079973-24-000776:0
- 246,305 shares0Common StockSEC:0001553350-21-001169:0
- 288,100 shares0Common StockSEC:0001553350-21-000010:0
- 900,000 shares0Common StockSEC:0001553350-20-000007:0
- 800,000 shares0Common StockSEC:0001553350-20-000001:0
- 900,000 shares0Common StockSEC:0001553350-20-000002:0
- 1,980,000 shares0Common StockSEC:0001553350-20-000002:1
- 800,000 shares0Common StockSEC:0001553350-19-000009:0
- 665,720 shares0Common StockSEC:0001553350-18-000033:0
- 16,349 sharesCommon StockSEC:0001553350-17-000463:0
- 76,070 sharesCommon StockSEC:0001553350-17-000463:1
- 179,333 sharesCommon StockSEC:0001553350-17-000463:2
- 75,000 shares0Common StockSEC:0001553350-17-000020:0
- 125,000 shares0Common StockSEC:0001553350-17-000020:1
- 10,842 shares@ US$0.09Common StockSEC:0001144204-15-020893:0
- 1,754 shares@ US$4.15Common StockSEC:0001553350-14-000582:0Canonical exit: 17 Aug 2014 (T+90)
- 400 shares@ US$4.05Common StockSEC:0001553350-14-000582:1Canonical exit: 17 Aug 2014 (T+90)
- 346 shares@ US$4.10Common StockSEC:0001553350-14-000582:2Canonical exit: 17 Aug 2014 (T+90)
- 1,160 sharesCommon StockSEC:0001553350-13-000465:0
- 51 sharesCommon StockSEC:0001553350-13-000465:1Canonical exit: 27 Oct 2013 (T+90)
20 of 20 declarations